• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

OPDP Enforcement Actions Webinar - April 30, 2012

 

The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in the fourth of our Enforcement Webinars, which was held on April 30, 2012. This is a pilot program in which OPDP gave our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by OPDP in a given quarter. This particular webinar covered Warning Letters and Untitled Letters issued from January 2012 to April 2012.
 
These focused webinars will support OPDP's mission to protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.  
 

 
If you have never attended a Connect Pro meeting before:
Test your connection: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm
Get a quick overview: http://www.adobe.com/go/connectpro_overview 
 
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.